Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses.
- Journal Article
Summary
This study investigated the combination of two different drugs, phenylbutazone and firocoxib, in horses, and found that the co-administration of these drugs for ten days could potentially lead to renal disease.
Objective of the Research
The research was primarily aimed at testing the impact of administering two different drugs, phenylbutazone and firocoxib together to horses over a ten day period. There were no previous records of this combination being tested together in horses, hence this study is pioneering that field. Phenylbutazone is a non-selective COX inhibitor, while firocoxib is a COX-2 specific NSAID.
- Horses were assessed daily for changes in behavior, appetite, fecal consistency, signs of abdominal pain, and oral mucous membrane ulceration.
- They also performed tests on the horses for changes in serum creatinine, albumin, total protein, and urine-specific gravity before and after the treatment.
- Moreover, endoscopic examination of the esophagus, stomach, and pylorus was carried out before and after the treatment.
Findings of the Study
Results drawn from the study were reasonably clear and led to one important finding.
- There was a significant increase in serum creatinine and total protein on the 10th day of treatment.
- No significant changes were noted in behavior, appetite, fecal consistency, signs of abdominal pain, and oral mucous membrane ulceration.
- Also, no notable changes were found in albumin and urine-specific gravity levels.
- Endoscopic studies of the esophagus, stomach, and pylorus also didn’t show any notable changes.
Conclusion of the Study
This study concluded that the combination of the drugs phenylbutazone and firocoxib administration for ten days could potentially lead to renal diseases in horses. Hence caution might be necessary while co-administering these drugs, as the significant increase in serum creatinine and total protein could indicate damage to the kidneys. However, the study didn’t note other significant impacts in the horses that were part of this research.
Cite This Article
Publication
Researcher Affiliations
- Foundation Equine Mobile Medicine and Dentistry, Southern Pines, NC, USA.
MeSH Terms
- 4-Butyrolactone / administration & dosage
- 4-Butyrolactone / adverse effects
- 4-Butyrolactone / analogs & derivatives
- Administration, Oral
- Animals
- Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
- Anti-Inflammatory Agents, Non-Steroidal / adverse effects
- Blood Proteins
- Creatinine / blood
- Drug Therapy, Combination
- Horse Diseases / blood
- Horse Diseases / chemically induced
- Horses
- Kidney Diseases / chemically induced
- Kidney Diseases / veterinary
- Phenylbutazone / administration & dosage
- Phenylbutazone / adverse effects
- Prostaglandin-Endoperoxide Synthases / metabolism
- Sulfones / administration & dosage
- Sulfones / adverse effects
Citations
This article has been cited 7 times.- Mercer MA, Davis JL, McKenzie HC. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses.. Animals (Basel) 2023 May 10;13(10).
- Mercer MA, Davis JL, McKenzie HC, Messenger KM, Schaefer E, Council-Troche RM, Werre SR. Pharmacokinetics and efficacy of orally administered acetaminophen (paracetamol) in adult horses with experimentally induced endotoxemia.. J Vet Intern Med 2023 Mar;37(2):718-727.
- Fadel C, Giorgi M. Synopsis of the pharmacokinetics, pharmacodynamics, applications, and safety of firocoxib in horses.. Vet Anim Sci 2023 Mar;19:100286.
- Flood J, Stewart AJ. Non-Steroidal Anti-Inflammatory Drugs and Associated Toxicities in Horses.. Animals (Basel) 2022 Oct 26;12(21).
- Donnell JR, Frisbie DD. Use of firocoxib for the treatment of equine osteoarthritis.. Vet Med (Auckl) 2014;5:159-168.
- Tesena P, Yingchutrakul Y, Roytrakul S, Wongtawan T, Angkanaporn K. Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone.. J Vet Med Sci 2019 Mar 20;81(3):418-424.
- Ziegler A, Fogle C, Blikslager A. Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses.. J Am Vet Med Assoc 2017 Jun 1;250(11):1271-1274.